F. B. Hagemeister
-
- Lymphoma Diagnosis and Treatment 21
- Oncology top 10%
- Viral-associated cancers and disorders 6
- Cancer Treatment and Pharmacology 3
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 5
-
- CNS Lymphoma Diagnosis and Treatment 3
-
- Lung Cancer Treatments and Mutations 7
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Thallium and Germanium Studies 1
- Co-authors
- Fernando CabanillasPeter McLaughlinJorge RomagueraRazelle KurzrockLuis FayadMaria Alma RodriguezJohn F. SeymourMoshe Talpaz
- Journals
- Journal of Clinical Oncology (3 papers)Blood (5 papers)The American Journal of Medicine (1 paper)
- Partner nations
- United StatesAustraliaGreece
In The Last Decade
F. B. Hagemeister
25 papers receiving 545 citations
Peers
Comparison fields: 5 of 64
- Pathology and Forensic Medicine 304
- Oncology 329
- Genetics 110
- Neurology 82
- Hematology 56
Countries citing papers authored by F. B. Hagemeister
This map shows the geographic impact of F. B. Hagemeister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. B. Hagemeister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. B. Hagemeister more than expected).
Fields of papers citing papers by F. B. Hagemeister
This network shows the impact of papers produced by F. B. Hagemeister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. B. Hagemeister. The network helps show where F. B. Hagemeister may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. B. Hagemeister, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2011 | 66 | |
| 3 | 2011 | 1 | |
| 4 | 2008 | 94 | |
| 5 | 2004 | 3 | |
| 6 | 2000 | 42 | |
| 7 | 1999 | 58 | |
| 8 | 1999 | 3 | |
| 9 | 1997 | 69 | |
| 10 | 1997 | 31 | |
| 11 | Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy. | 1994 | 21 |
| 12 | 1992 | 93 | |
| 13 | 1992 | 23 | |
| 14 | 1991 | 8 | |
| 15 | 1989 | 4 | |
| 16 | Activity of bisantrene in refractory lymphoma. | 1987 | 4 |
| 17 | Pulmonary toxicity associated with spirogermanium. | 1984 | 7 |
| 18 | Hodgkin's disease stage I and II. Management considerations and results in adults | 1983 | 2 |
| 19 | Treatment options for stage III Hodgkin's disease | 1983 | 1 |
| 20 | Prognostic factors for stage IV Hodgkin's disease (HD) treated with MOPP | 1982 | 2 |
About F. B. Hagemeister
F. B. Hagemeister is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 25 papers that have together received 564 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (7 papers), Viral-associated cancers and disorders (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Cancer Treatment and Pharmacology (3 papers) and Thallium and Germanium Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (304 citations), Oncology (329 citations) and Genetics (110 citations). F. B. Hagemeister has collaborated with scholars based in United States, Australia and Greece. Frequent co-authors include Fernando Cabanillas, Peter McLaughlin, Jorge Romaguera, Razelle Kurzrock, Luis Fayad, Maria Alma Rodriguez, John F. Seymour, Moshe Talpaz, F Swan and Lillian M. Fuller. Their work appears in journals such as Journal of Clinical Oncology, Blood and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.